Genmab | GEN - Lngresos Netos

Precio De Mercado
1,639.00
Cambio Diario
-119.50 -6.80%
Mensual
-9.07%
Anual
24.26%
Q2 Expectativa
1,613.20




Lngresos Netos Cambio Fecha
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Almirall EUR 19.58M 7M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 1.82B 486M 2026-03
argenx SE USD 366M 166.95M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR -3.76B 2.79B 2025-12
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Demant DKK 427M 690M 2025-12
Exelixis USD 244.53M 50.95M 2025-12
Fresenius Medical Care EUR 118M 209M 2026-03
Galapagos EUR 782.15M 984.26M 2025-12
Genmab DKK 31M 370M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GN Store Nord DKK -955M 1.3B 2026-03
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Lonza CHF 426M 119M 2025-06
Merck EUR 319M 583M 2025-12
Novartis USD 3.16B 747M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
UCB EUR 1.08B 608M 2025-12